A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma
PHASE1RecruitingINTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
December 30, 2024
Primary Completion Date
October 13, 2025
Study Completion Date
July 13, 2026
Conditions
B-Cell Non-Hodgkin Lymphoma
Interventions
DRUG
CAR T cells
chimeric antigen receptor T cells
Trial Locations (1)
200065
RECRUITING
Shanghai Tongji Hospital, Shanghai
All Listed Sponsors
lead
Aibin Liang，MD，Ph.D.
OTHER
NCT06734871 - A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma | Biotech Hunter | Biotech Hunter